Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature.
BACKGROUND
Although several studies did not demonstrate that daptomycin may cause significantly higher rates of pulmonary adverse effects when compared with vancomycin or penicillinase-resistant penicillins, there have been a few case reports of severe pulmonary complications associated with daptomycin administration.


METHODS
A rare case of eosinophilic pneumonia occurring 10 days after daptomycin administration in a 78-year-old Caucasian man with possible infectious endocarditis is described. He developed new onset fever, up to 38.5°C, with bilateral pulmonary crackles on physical examination and with no signs of severe respiratory failure. A chest computed tomography-scan showed bilateral nodular consolidations with air bronchograms and pleural effusions. Immediate discontinuation of daptomycin was followed by vigorous improvement of clinical signs and symptoms with progressive resolution of pulmonary consolidations a month later.


CONCLUSIONS
Physicians should be aware of this rare but serious complication during daptomycin treatment, and prompt discontinuation of the offending agent, with or without additional supportive treatment, must occur immediately.
5th Department of Internal Medicine and Infectious Diseases, "EVANGELISMOS" General Hospital, 45-47 Ipsilantou Street, 106 76 Kolonaki, Athens, Greece. andkalog@gmail.com.
Andreas S
AS
Kalogeropoulos
Sotirios
S
Tsiodras
Dionysios
D
Loverdos
Panagiotis
P
Fanourgiakis
Athanasios
A
Skoutelis
Clin Chest Med. 2004 Mar;25(1):77-88
15062599
Int J Antimicrob Agents. 2009 Jun;33(6):543-8
19201165
Semin Respir Crit Care Med. 2006 Apr;27(2):192-7
16612770
Expert Opin Pharmacother. 2010 Mar;11(4):615-25
20163272
Clin Infect Dis. 2004 Jun 15;38(12):1673-81
15227611
J Infect. 2009 Feb;58(2):173-4
19046602
Am J Respir Crit Care Med. 2002 Nov 1;166(9):1235-9
12403693
J Infect. 2007 Apr;54(4):e211-3
17207858
Clin Infect Dis. 2010 Mar 1;50(5):737-40
20121418
Ann Pharmacother. 2009 Jul;43(7):1211-9
19584384
J Infect Dis. 2005 Jun 15;191(12):2149-52
15898002
J Cardiothorac Surg. 2010 Mar 23;5:13
20331896
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
7249508
Eur Respir J Suppl. 2001 Sep;32:93s-100s
11816828
Ann Pharmacother. 2007 Apr;41(4):696-701
17374626
Clin Infect Dis. 2009 Jul 15;49(2):177-80
19500039
N Engl J Med. 2006 Aug 17;355(7):653-65
16914701
Clin Rheumatol. 2007 Apr;26(4):590-5
16440133